PeptideStack
5.2kquestions
20kanswers
220users

Is 15 mg in 3 mL of phosphate-buffered diluent a sensible presentation for orforglipron?

Asked 5 Dec 2025Modified 5 months agoViewed 7.2k times
8

For reference: 15 mg · 3 mL · phosphate-buffered diluent · orforglipron.

I would like to define my thresholds before I have a result, for obvious reasons.

I want a plan with explicit stopping rules, not just steps.

How do I make this decision on evidence rather than on feel?

diluent-volume
diluent-volume

Choosing how much diluent to add, which is really a question about what you want your measurement resolution to be. Larger volumes buy you…

295 questions
reconstitution
reconstitution

Taking a lyophilised vial to a solution of known concentration: choice of diluent, volume selection, how to add liquid without shearing the cake,…

313 questions
dosing-math
dosing-math

The arithmetic itself: milligrams to millilitres to insulin units, concentration after reconstitution, dose per draw, and vial-days per vial. Show…

764 questions
orforglipron
orforglipron

A non-peptide, orally bioavailable small-molecule GLP-1 receptor agonist studied in the ATTAIN programme. It is not a peptide, which changes…

219 questions
shareeditfollowflag
NK
askednils_karlberg9.4k155 Dec 2025

4 Answers

Accepted answer first, then by votes
49

Accepted answer

It gives 5 mg/mL, and whether that is sensible depends on the dose you will draw from it. 15 ÷ 3 = 5 mg/mL in phosphate-buffered diluent. A 0.5 mg dose is then 10 units on a U-100 barrel and a 1 mg dose is 20 units. Both land in a readable part of the barrel, which is the whole point of choosing the volume deliberately.

The short version: more diluent means a lower concentration, a larger volume per dose and a finer reading; less means the opposite.

Worked example. A 10 mg vial reconstituted with 2 mL gives 5 mg/mL. A 0.5 mg dose is 0.5 ÷ 5 = 0.1 mL, which on a U-100 syringe is 10 units. Reconstitute the same vial with 1 mL and the concentration doubles to 10 mg/mL, the same dose becomes 0.05 mL, and you are now reading 5 units instead of 10 — the same dose at half the resolution.

Dead space by syringe type

ConfigurationDead volumeLoss at 5 mg/mLOver 20 draws
Fixed-needle insulin syringe3–5 µL15–25 µg0.3–0.5 mg
Low-dead-space, detachable<2 µL<10 µg<0.2 mg
Standard luer-lock + 30G35–60 µL175–300 µg3.5–6 mg
Luer-lock + 21G drawing needle70–100 µL350–500 µg7–10 mg

Stated carefully, content matters. If the same 10 mg vial assays at 94 per cent content, you have 9.4 mg. In 2 mL that is 4.7 mg/mL, and a nominal 0.5 mg draw of 10 units actually delivers 0.47 mg — a six per cent shortfall that no amount of careful drawing will fix.

U-100 means 100 units per millilitre by definition, so 1 unit is 0.01 mL and volume in millilitres times one hundred gives units. Every conversion here reduces to that.

Choose the volume that puts your largest intended dose between 10 and 30 units. Everything else follows.

shareimprove this answerflag
LC
answered · acceptedlyoph_cake78k26724 Feb 2026
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results
40

The relevant arithmetic is concentration equals vial content divided by diluent volume, and content is not the same as label claim.

The other direction: 10 mg in 3 mL is 3.33 mg/mL, and a 0.5 mg dose becomes 0.15 mL, or 15 units. More barrel, easier reading, and a larger fraction of the vial volume lost to dead space across the same number of draws.

Round to a diluent volume you can measure accurately. Measuring 1.00 mL on a 1 mL syringe is reliable; measuring 1.37 mL on anything is not, and the error propagates into every dose.

Nominal vial volumes in the standard 2R and 3R glass sizes have published brimful capacities well above the nominal fill, but the usable volume is bounded by the stopper displacement.

Check the vial can physically hold the volume before you draw it up.

shareimprove this answerflag
TO
answeredt_oyelaran79k488 Mar 2026
The arithmetic checks out. I ran the same numbers and got the same result. – Dr_Ilse_Vandenberg 7 months ago
add a comment
19

The honest answer is that a wide range of volumes works and that the extremes at either end cause avoidable problems.

Dead-space loss scales with the number of draws, not with the concentration, so a lower concentration spread over more draws loses proportionally less of the total peptide.

Vial headspace is the hard constraint. A nominal 2 mL vial typically holds a little over 2 mL to the shoulder; adding 3 mL is not an option and attempting it wastes the lot.

A concentration calculated to three decimal places from a diluent volume measured to one is false precision.

Measure a volume you can actually measure. Round numbers, real syringes.

shareimprove this answerflag
EV
answeredesther_vandeVelde52k2713 Feb 2026
16

Total vial volume is a physical constraint: most 2 mL vials will not take 3 mL of anything.

For a dose that will change during titration, choose the volume for the largest intended dose rather than the first, so the whole schedule fits on one barrel without a mid-vial recalculation.

Nothing here is medical advice, and research-use material is not approved for human use.

Write the concentration on the label at reconstitution, in units per dose.

shareimprove this answerflag
TM
answeredthabo_maseko28k382 Feb 2026

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.